NCT00403624View on ClinicalTrials.gov

Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Rectal Neoplasms

Interventions

DRUG

OXALIPLATIN

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY